Next Article in Journal
Selective Surface Electrostimulation of the Denervated Zygomaticus Muscle
Next Article in Special Issue
Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [68Ga] Pentixafor Internalization in Neuroendocrine Tumor Cells
Previous Article in Journal
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
Previous Article in Special Issue
Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition
Article

Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with 177Lu-PSMA

1
Department of Nuclear Medicine, University Hospital Bonn, 53127 Bonn, Germany
2
Department of Computer Science, University of Bonn, 53115 Bonn, Germany
*
Author to whom correspondence should be addressed.
Academic Editor: Rudolf A. Werner
Diagnostics 2021, 11(2), 186; https://doi.org/10.3390/diagnostics11020186
Received: 6 January 2021 / Revised: 24 January 2021 / Accepted: 25 January 2021 / Published: 28 January 2021
(This article belongs to the Special Issue Novel Theranostic Agents)
Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PSMA-PET/CT) scans can facilitate diagnosis and treatment of prostate disease. Radiomics signature (RS) is widely used for the analysis of overall survival (OS) in cancer diseases. This study aims at investigating the role of radiomics features (RFs) and RS from pretherapeutic gallium-68 (68Ga)-PSMA-PET/CT findings and patient-specific clinical parameters to analyze overall survival of prostate cancer (PC) patients when treated with lutethium-177 (177Lu)-PSMA. A cohort of 83 patients with advanced PC was retrospectively analyzed. Average values of 73 RFs of 2070 malignant hotspots as well as 22 clinical parameters were analyzed for each patient. From the Cox proportional hazard model, the least absolute shrinkage and selection operator (LASSO) regularization method is used to select most relevant features (standardized uptake value (SUV)Min and kurtosis with the coefficients of 0.984 and −0.118, respectively) and to calculate the RS from the RFs. Kaplan–Meier (KM) estimator was used to analyze the potential of RFs and conventional clinical parameters, such as metabolic tumor volume (MTV) and standardized uptake value (SUV) for the prediction of survival. As a result, SUVMin, kurtosis, the calculated RS, SUVMean, as well as Hemoglobin (Hb)1, C-reactive protein (CRP)1, and ECOG1 (clinical parameters) achieved p-values less than 0.05, which suggest the potential of findings from 68Ga-PSMA-PET/CT scans as well as patient-specific clinical parameters for the prediction of OS for patients with advanced PC treated with 177Lu-PSMA therapy. View Full-Text
Keywords: prostate cancer (PC); prostate specific membrane antigen (PSMA); positron emission tomography (PET); computed tomography (CT); overall survival (OS); radiomics signature (RS) prostate cancer (PC); prostate specific membrane antigen (PSMA); positron emission tomography (PET); computed tomography (CT); overall survival (OS); radiomics signature (RS)
Show Figures

Figure 1

MDPI and ACS Style

Moazemi, S.; Erle, A.; Lütje, S.; Gaertner, F.C.; Essler, M.; Bundschuh, R.A. Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with 177Lu-PSMA. Diagnostics 2021, 11, 186. https://doi.org/10.3390/diagnostics11020186

AMA Style

Moazemi S, Erle A, Lütje S, Gaertner FC, Essler M, Bundschuh RA. Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with 177Lu-PSMA. Diagnostics. 2021; 11(2):186. https://doi.org/10.3390/diagnostics11020186

Chicago/Turabian Style

Moazemi, Sobhan; Erle, Annette; Lütje, Susanne; Gaertner, Florian C.; Essler, Markus; Bundschuh, Ralph A. 2021. "Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with 177Lu-PSMA" Diagnostics 11, no. 2: 186. https://doi.org/10.3390/diagnostics11020186

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop